Dogwood Therapeutics DWTX Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Preferred Shares Issued
Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Preferred Shares Issued at other companies
Other financials
Where this comes from
Reported directly by Dogwood Therapeutics in its filing.
Tagged under the XBRL concept dwtx:NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationPreferredSharesIssued.
The official record: Dogwood Therapeutics’s 10-K, filed March 18, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dogwood Therapeutics's noncash or part noncash acquisition noncash financial or equity instrument consideration preferred shares issued.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dogwood Therapeutics's noncash or part noncash acquisition noncash financial or equity instrument consideration preferred shares issued?
- Dogwood Therapeutics (DWTX) reported noncash or part noncash acquisition noncash financial or equity instrument consideration preferred shares issued of $17.59M in Q4 2024.
- What does noncash or part noncash acquisition noncash financial or equity instrument consideration preferred shares issued mean?
- Captures the value of preferred shares issued as non-cash consideration for the acquisition of assets, businesses, or intellectual property. This metric highlights the company's ability to execute strategic growth initiatives without utilizing cash reserves. It is a key indicator of how the company leverages its capital structure to facilitate inorganic growth.